Search Results 291-300 of 19426 for B cell lymphomas
The purpose of this study is to provide access to CTL019 through Managed Access Program (MAP) for acute lymphoblastic leukemia (ALL) or diffuse large b-cell ...
... B-cell lymphoma with MYC gene, and BCL2 gene rearrangements known as double-hit lymphomas and large B-cell lymphomas with IRF4 gene rearrangements.
She is board certified in internal medicine, medical oncology, and hematology, and has a special interest in T-cell lymphomas ... B-cell lymphoma · Cutaneous t- ...
The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...
... B-cell lymphoma 2 (BCL2) inhibitor. A Study to Evaluate Immune and Hematopoietic Cell Assessment in Clonal B Cell Conditions. Rochester, Minn. The purpose of ...
Sixty percent of patients had a diagnosis of diffuse large B-cell lymphoma, 14 percent mantle cell lymphoma, 11 percent grade III follicular lymphoma, 13 ...
CAR-T cell therapy aimed at killing B-cell blood ... multiple myeloma, leukemias and lymphomas. Manufacturing CAR-T cells ... lymphoma. Known as CAR-T cell therapy, ...
Lymphoma could be regarded as a cancer of the white blood cells, cancer of the immune system or cancer of the blood, in essence, because of the origin of the ...
Basal cell carcinoma; Cancer that spreads to the skin; Cutaneous B-cell lymphoma; Cutaneous T-cell lymphoma; Dermatofibrosarcoma protuberans; Extramammary ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.